Skip to main content
. Author manuscript; available in PMC: 2024 Jul 17.
Published in final edited form as: Clin Cancer Res. 2024 Jan 17;30(2):274–282. doi: 10.1158/1078-0432.CCR-23-1200

Table 1:

Patient Characteristics

Category number

Age, median [years (range)] 52 (25–69)
Biological Sex Male 16
Female 9
Diagnosis at HCT
AML 20
2` secondary AML 8
1` primary AML 12
MDS refractory 1
ALL 4
T-cell ALL 2
CML transformed to Ph+ ALL 1
B-cell ALL 1
Prior Allo-HCT 7
Risk Group - by ELN 2017 Criteria
2` AML Favorable 0
Intermediate 4
High 4
1` AML Favorable 1
Intermediate 9
High 2
MDS High 1
ALL High 4